Showing posts with label anti-inflammatory. Show all posts
Showing posts with label anti-inflammatory. Show all posts

Monday, June 29, 2015

Health Research: Light fixture kills bacteria safely ♦ Endogenous proteins as anti-inflammatory agents ♦ New strategies for combating chronic kidney disease,

Light fixture kills bacteria safely, continuously A new light fixture uses Continuous Environmental Disinfection technology to continuously kill harmful bacteria linked to hospital acquired infections (HAIs). The technology behind the Indigo-Clean™ inactivates a wide range of microorganisms that are known causes of HAIs, including MRSA (Methicillin-resistant Staphylococcus aureus), C.difficile and VRE (Vancomycin-resistant Enterococcus).
Endogenous proteins as anti-inflammatory agents In autoimmune diseases and immune pathologies such as rheumatoid arthritis, psoriasis or organ rejection, inflammatory processes take place in the body, triggered by its own immune system. New research is concentrating on a special protein that is thought to play an important role in controlling excessive immune reactions.
Long-acting antipsychotic medication may improve treatment for schizophrenia An injectable drug given every two weeks works better than a daily pill for those who have been recently diagnosed with schizophrenia.
Medically complex patients with Type 2 diabetes could benefit from seeing a specialist soon People recently diagnosed with Type 2 diabetes and who have other serious chronic health issues have less heart disease and lower death rates if they see an endocrinologist within one year of diagnosis.
New strategies for combating chronic kidney disease, other long-term conditions New strategies for using electronic health records (EHRs) to treat patients with chronic kidney disease have been outlined by investigators. Their recommendations may help clinicians and hospitals better manage individual patients with chronic conditions and identify groups of patients most likely to benefit from different treatment strategies.

Friday, April 24, 2015

Health News Nanoparticle drug reverses Parkinson's-like symptoms ♦ A fountain of youth for aging muscles ♦ Disease Caused By Emulsifiers

Food Additives: chronic Disease Caused By Emulsifiers Have you ever wondered what those food additive numbers in the ingredients list on your food packaging meant and what they were really doing to your body? Emulsifiers – detergent-like food additives found in processed foods – have the potential to damage the intestinal barrier, leading to inflammation and increasing our risk of chronic disease
Computer-assisted diagnosis tool helps physicians assess skin conditions without aid from dermatologists In the first major study to examine the use of a computer-assisted, photo-driven differential diagnosis generator for skin conditions, researchers found physicians routinely used the tool, without an increase in calling for inpatient dermatology consultations.
A fountain of youth for aging muscles? Caloric restriction has been studied as a way to increase longevity in animals. Now, researcher explore how it may positively affect muscle and find that aging muscles receive the most benefit. Calorie restriction is thought to have a protective effect on muscle cells and may help cells better use antioxidants, avoid damage caused by free radicals and function better.
Nanoparticle drug reverses Parkinson's-like symptoms in rats As baby boomers age, the number of people diagnosed with Parkinson's disease is expected to increase. Patients who develop this disease usually start experiencing symptoms around age 60 or older. Currently, there's no cure, but scientists are reporting a novel approach that reversed Parkinson's-like symptoms in rats. Their results could one day lead to a new therapy for human patients.
Scientists X-ray anti-inflammatory drug candidates Using an ultra bright X-ray source, scientists have decoded the molecular and three-dimensional structure of two promising drug candidates. The results provide a deeper understanding of the mode of action of these substances that have already entered clinical trials.
;